Author:Qingfeng Pharmaceutical Group
Posted Time:2025-01-06 00:00
Qingfeng Pharmaceutical Group, will attend “The 43rd Annual J.P. Morgan Healthcare Conference” in San Francisco, from January 13-16, 2025. Qingfeng would like to hold one-on-one meetings with potential global partners to explore international cooperation on out/in license of innovative drugs.
About J.P. Morgan Healthcare Conference
J.P. Morgan Healthcare Conference is one of the world's largest and most influential healthcare investment seminars and is held every January in San Francisco, USA. The conference brings together high-level pharmaceutical and biotechnology enterprises, innovative entrepreneurs and investment and financing experts from around the world to discuss the frontier trends and cooperation opportunities. The 43rd jpmorgan Healthcare Conference 2025 will be held from January 13 to 16 and will focus on pharmaceutical innovation, M&A trends and international collaborations . The conference will continue to serve as an important weathervane in the field of biomedicine and life science to promote industry innovation and development.
About Qingfeng Pharma
Qingfeng Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical enterprise group integrating research and development, manufacture and commercialization. Driven by innovative research and development, we have built a collaborative and efficient drug innovation platform in Shanghai, Beijing, Hangzhou, and Ganzhou, focusing on four areas include anti-infection, Gastroenterology, CNS, and oncology, and has developed a series of attractive innovative pipeline. For the cooperation innovative drugs, Qingfeng is actively seeking partners with open attitudes.
